PEOPLE WITH MULTIPLE MYELOMA MAY NOW EXPERIENCE FEWER SIDE EFFECTS OF TREATMENT, ELIZABETH TRACEY REPORTS
Multiple myeloma, a type of blood cancer, is a killer, and some have said the treatment is worse than the disease. Now a study in the New England Journal of Medicine optimizing the dosage of one of the standards of care may help. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, explains.
NELSON: What these people turned around and asked is is it possible that thereís a dose somewhere in between very high dose and low dose that gets you better leukemia killing but less side effects? And so they used an intermediate dose, compared it to the high dose and found that they were equally good at inducing a remission as initial treatment for leukemia, but the intermediate dose did have in fact less side effects. So it may be a better way, get the disease under control so someone can go on to get their definitive treatment to hopefully cure the disease. :30
Nelson says the strategy should reduce at least some side effects of treatment. At johns Hopkins, Iím Elizabeth Tracey.